Search

Displaying results 8341 - 8350 of 10000 in total
  1. Drug

    PD-217014

    go.drugbank.com/drugs/DB12493
    Investigational

    PD-217,014 has been used in trials studying the treatment of Pain and Irritable Bowel Syndrome.

  2. Drug

    NVS antibody

    go.drugbank.com/drugs/DB05312
    Experimental

    This drug has been developed using Medarex's UltiMAb Human Antibody Development System to treat autoimmune diseases.

  3. Drug

    Seletalisib

    go.drugbank.com/drugs/DB12706
    Investigational

    Seletalisib has been used in trials studying the treatment and basic science of Primary Sjogren's Syndrome.

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
  4. Drug

    Pelitrexol

    go.drugbank.com/drugs/DB12757
    Investigational

    Pelitrexol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

    Categories: Heterocyclic Compounds, 1-Ring
  5. Drug

    Timcodar

    go.drugbank.com/drugs/DB12761
    Investigational

    Timcodar has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

    Categories: Heterocyclic Compounds, 1-Ring
  6. Drug

    Intoplicine

    go.drugbank.com/drugs/DB12868
    Investigational

    Intoplicine has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
  7. Drug

    Falnidamol

    go.drugbank.com/drugs/DB12966
    Investigational

    Falnidamol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

  8. Drug

    Miridesap

    go.drugbank.com/drugs/DB13087
    Investigational

    Miridesap has been used in trials studying the prevention of HIV and treatment of AL amyloidosis.

    Synonyms: 1,1'-hexanedioyldi-D-prolineCategories: Heterocyclic Compounds, 1-Ring
  9. Drug

    Psicose

    go.drugbank.com/drugs/DB15087
    Experimental

    Psicose is under investigation in clinical trial NCT02459834 (The Fructose and Allulose Catalytic Effects (FACE) Trial).

  10. Drug

    NKTT-120

    go.drugbank.com/drugs/DB17730
    Investigational

    NKTT-120 is a recombinant humanized IgG1k monoclonal antibody to human invariant T cell receptor (iTCR).